Fibronectin is known to decrease neuronal growth cone velocity in vitro (52) and contribute to remyelination failure within multiple sclerosis lesions (53), thus suggesting that a fibronectin-dense scar might interfere with axon regeneration, while decreased fibronectin deposition could ameliorate functional recovery. This evidence concerns the gene FN1 and multiple sclerosis.